FDA Tells Stem Cell Cos. Regulatory Eyes Fixed On Them
The U.S. Food and Drug Administration on Thursday said it has sent a warning letter to Genetech Inc. for marketing "dangerous unapproved stem cell products," as well as to other clinics...To view the full article, register now.
Already a subscriber? Click here to view full article